Market Overview

Why Precipio's Stock Is Rocketing Higher Today

Why Precipio's Stock Is Rocketing Higher Today

Precipio (NASDAQ: PRPO) shares are trading higher on Thursday.

The company announced it entered into an agreement with ADS Biotec to distribute its FDA-authorized COVID-19 serology antibody tests that recently received Emergency Use Authorization.

Precipio is a diagnostics company, which has built a platform designed to eradicate the problem of misdiagnosis by harnessing the expertise and technology developed within academic institutions and delivering diagnostic information to physicians. The company's platform delivers diagnostic accuracy through academic expertise and cutting-edge technology.

It operates as a laboratory focused on delivering specialized diagnostic services to physicians and their patients to ensure they receive accurate results.

Precipio shares were trading up 371% at $5.80 at the time of publication on Thursday. The stock has a 52-week high of $8 and a 52-week low of 55 cents.


Related Articles (PRPO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at